Somewhat Favorable Press Coverage Somewhat Unlikely to Impact National Research Corporation (NRCIA) Stock Price
Media headlines about National Research Corporation (NASDAQ:NRCIA) have been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. National Research Corporation earned a news sentiment score of 0.09 on Accern’s scale. Accern also gave media stories about the business services provider an impact score of 46.8547542944523 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Shares of National Research Corporation (NRCIA) opened at 32.95 on Friday. The firm has a market cap of $800.65 million, a P/E ratio of 36.29 and a beta of 1.68. National Research Corporation has a one year low of $14.35 and a one year high of $33.15. The firm has a 50-day moving average price of $30.06 and a 200 day moving average price of $24.70.
Separately, Zacks Investment Research downgraded National Research Corporation from a “buy” rating to a “hold” rating in a report on Saturday, August 12th.
About National Research Corporation
National Research Corporation provides analytics and insights for the patient and employee experience in serving the healthcare providers, payers, and other healthcare organizations in the United States and Canada. Its portfolio of subscription-based solutions offer information and analysis services in a range of elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.
Receive News & Stock Ratings for National Research Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corporation and related stocks with our FREE daily email newsletter.